CS Paper Radar

An interpretable deep learning method for early hepatocellular carcinoma diagnosis on multiphase CT

Emma Sarfati, Alexandre Bône, Pietro Gori, Sisi Yang, Marc-Michel Rohé, François Nicolas, Jeong-Min Lee, Jeong Hee Yoon, Maxime Ronot, Isabelle Bloch, Christophe Aubé

cs.CV cs.AI ·submitted 2026-10-21 11:56 UTC · v1
publishedhot direction

Abstract

Early diagnosis of hepatocellular carcinoma is critical to preserve access to curative treatment options. The Liver Imaging Reporting and Data System (LI-RADS) provides a standardized framework for non-invasive diagnosis on multiphase computed tomography, based on major visual imaging features. However, these features may be difficult to assess consistently, particularly in small liver lesions. We developed dLI-RADS, an interpretable artificial intelligence method designed to estimate the probability of hepatocellular carcinoma from multiphase computed tomography images of manually segmented liver lesions, while remaining aligned with LI-RADS-related imaging concepts. dLI-RADS combines neural network-derived predictions with handcrafted quantitative imaging measurements reflecting LI-RADS major features and integrates these inputs using logistic regression. In this multicenter retrospective study, patients with multiphase computed tomography and at least one liver lesion were included, while lesions larger than 40 mm were excluded. Histology served as the reference standard for hepatocellular carcinoma, and a composite reference standard was used for non-hepatocellular carcinoma lesions. The lesion-level accuracy of dLI-RADS and LI-RADS were compared on the internal evaluation set using 10,000-repetition bootstrap non-inferiority tests, with 5% margins and significance levels. On the external test set, sensitivities were similarly compared. dLI-RADS was non-inferior to LI-RADS for lesion-level accuracy in the internal evaluation set, achieving 80% accuracy compared with 74% for LI-RADS (p = 0.04)...

Comment
Accepted at Scientific Reports

Closest papers

Nearest neighbours by meaning across the whole index.

AMPLIFAI: A Multiphase CT Dataset for Benchmarking Clinical Reasoning in LI-RADS Assessment of Liver Lesions

cs.CV cs.LG ·2026-08-14 ·Pranav Kulkarni, Nikhil Shah, Amritansh Suryavanshi, Jana G. Delfino, James Tonascia +7 more
dataset similarity 0.82
Abstract · 15 pages, 6 figures, 3 tables

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide, with early detection improving survival from <20% to >70%. The standardized Liver Imaging Reporting and Data System (LI-RADS) criteria provide an imaging-based diagnostic framework to evaluate liver lesions for HCC, serving as a foundation for automating HCC detection with artificial intelligence (AI). However, the lack of large, publicly available datasets with high-quality annotations has limited the development and evaluation of AI models for automated LI-RADS assessment. We introduce AMPLIFAI dataset, the first public dataset of 590 multiphase abdominal CT studies annotated with LI-RADS categories, lesion size, and voxel-level segmentations for three major LI-RADS features: arterial phase hyperenhancement, washout, and enhancing capsule. The dataset was curated and harmonized from four public datasets and augmented with expert annotations from five board-certified radiologists and one resident. Following the Datasheets for Datasets format, this paper details the dataset's composition, curation and harmonization process, and annotation workflow to support transparent, reproducible research in medical imaging AI.

0.10

LiFUSE: Frequency-Spatial Unified Self-Supervised Pretraining for Liver Disease Analysis on Non-contrast CT

cs.CV cs.AIcs.LG ·2026-10-13 ·Hao Zhang, Yi Huang, Wei Liu, Yuan Gao, Zeju Li +4 more
published similarity 0.71
Abstract · Accepted at the 2026 IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2026)

Given the growing global burden of liver tumors and diffuse liver diseases, non-contrast computed tomography (NCCT) is increasingly used for opportunistic screening because of its low cost and favorable safety profile. However, downstream tasks such as tumor detection and fine-grained disease diagnosis remain challenging due to NCCT's inherently low tissue contrast, lack of hemodynamic enhancement, and complex anatomical background. These limitations make subtle, heterogeneous, and multifocal hepatic lesions difficult to identify. Although large-scale self-supervised pretraining can learn robust representations from unlabeled NCCT scans, conventional voxel-wise reconstruction does not fully exploit the complementary information available in NCCT. Under weak NCCT contrast, low-level intensity patterns become less informative for pathology recognition, limiting the capture of lesion-specific discriminative features. In this paper, we propose the Liver Frequency-Spatial Unified Self-Supervised Pretraining (LiFUSE). The frequency branch applies random band-stop masking and spectrum reconstruction to encourage the model to capture subtle differences between lesions and surrounding tissues, while the spatial branch performs hybrid-granularity masked volumetric reconstruction to accommodate lesions of diverse sizes and morphologies. Finally, a cross-domain consistency scheme couples the spatial and frequency branches, yielding more discriminative representations for hepatic structures and lesions. Extensive experiments on three clinically relevant tasks across internal cohorts and a public target-domain transfer setting show that LiFUSE consistently outperforms strong baselines. These results suggest that unified frequency-spatial learning can improve liver disease analysis on NCCT, highlighting its potential for large-scale screening.

0.16

Potential of Artificial Intelligence Algorithms for Identification of Relevant Diagnostic and Prognostic Biomarkers of Early-Stage Liver Cancer

cs.AI ·2026-09-14 ·Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba +2 more
hot direction similarity 0.71
Abstract · 25 pages, 11 figures, 4 tables, under review

This study explores the use of deep learning and explainable artificial intelligence to diagnose hepatocellular carcinoma (HCC) and define effective biomarkers across five different stages of disease development using a transcriptomic biomarker HCC dataset constructed via semi-supervised learning from three source datasets. Several deep learning experiments were conducted with different feature extraction techniques and gene sets to identify the most effective features for training high-accuracy models with minimal loss. The best-performing model, using 15 selected genes with the SelectKBest algorithm, achieved 90.74% accuracy, while the model with the lowest recorded loss of 0.3187 was obtained using 20 selected genes. To address the issue of class imbalance in the dataset, a weighted training approach was conducted, and for model transparency and interpretability a SHAP-based XAI analysis provided insights into the model's decision-making, consistently finding DNAJB14 as the most influential gene. Functional validation in this study has provided compelling evidence that DNAJB14 plays an important role in the adverse properties of HCC and that its inhibition effectively reverses tumour cell migration, invasion, colony and sphere formation. The main limitation of this study is the dataset's class imbalance, and while weighted training helped mitigate this, further research and additional data are needed to guarantee model generalizability. Future studies should also explore the influence of genetic variations, environmental factors, and clinical differences on model performance across diverse populations.

0.34

Towards Reliable AI-Based Histological Staining: A Systematic Study of Scaling and Uncertainty in Unpaired Generative Models

cs.CV ·2026-08-25 ·Qasim Siddiqui, Adrian Friebel, Maiju Myllys, Zaynab Hobloss, Daniela Gonzalez +2 more
benchmarkcode/data similarity 0.68
Abstract · 37th British Machine Vision Conference, November 2026, Lancaster, UK

Liver fibrosis, the principal predictor of long-term outcome in chronic liver disease, is staged from histological estimates of collagen content. Sirius Red (SR) provides the standard quantitative readout (collagen proportionate area, CPA) but is not acquired at every clinical centre and consumes tissue, time, and reagent cost beyond the routine Hematoxylin and eosin (H&E) stain. AI-based virtual staining can generate SR directly from H&E, yet systematic benchmarks of unsupervised models are scarce and their predictive uncertainty has not been quantified, even though visually plausible outputs may not faithfully reproduce the underlying tissue structure. We therefore benchmark six unsupervised image-to-image architectures (GAN-based and diffusion-based) across 54 scaling configurations on a newly released paired H&E to SR mouse liver dataset, the first open resource for this translation task. Each configuration is evaluated jointly on perceptual, distributional, and task-specific axes plus a blinded expert reader study; the best per family is then retrained as a deep ensemble, the first systematic comparison of epistemic uncertainty across unsupervised stain-to-stain architectures. Across families, perceptual quality, task-specific error, and ensemble agreement measure largely independent axes of model fitness: GAN-based methods cluster tightly on perceptual metrics yet differ substantially on task error and ensemble agreement, while the diffusion-based method (CycleDiffusion) is qualitatively different on all three. No single metric captures these differences, so reliable virtual staining requires reporting and selecting on all three jointly. The dataset, tiling pipeline, models, and evaluation code are released publicly.

0.24

An Agentic AI Workflow for Liver Lesion Segmentation and Structured Radiology Reporting

cs.CV cs.LG ·2026-10-25 ·Fatma Ahmed Mansour, Rahatara Ferdousi, Zyad Medhat Mahmoud Ashor, Manar Fathy Elshenawy, Ibrahim Shehaby +2 more
similarity 0.67
Abstract

Despite advances in automated liver lesion segmentation, a gap remains between image-derived predictions and clinically interpretable radiology reports. Bridging this gap requires quantitative measurements that are both reproducible and traceable. We present an evidence-grounded agentic AI framework that connects liver and lesion segmentation with deterministic quantification and structured reporting. TotalSegmentator-based nnU-Net models delineate the liver, Couinaud segments, and lesions, while computational tools extract volumes, dimensions, counts, and anatomical locations. A large language model (LLM) organizes these measurements into a predefined reporting schema, with numerical consistency checks against source measurements. On 51 LiTS cases, the segmentation stage achieved a liver Dice score of 0.947, lesion sensitivity of 75.6%, and positive predictive value of 68.9%. Exploratory screening of 25,494 MERLIN reports identified 10,208 (40.0%) with liver-related abnormalities. By connecting quantitative imaging evidence with agentic report generation, this work takes a step toward human-centered medical AI that prioritizes traceability and clinical relevance.

0.23

Diagnosis by Composition: Detecting and Localizing Unseen Diseases by Composing Learned Radiological Findings

cs.CV ·2026-11-03 ·Kaihua Hou, Wei Liu, Yi Huang, Hao Zhang, Haibo Jin +8 more
similarity 0.66
Abstract

Deep models for radiological diagnosis are typically trained to predict disease labels directly from images, which limits them to diseases seen during training and makes their decisions hard to interpret in radiologists' terms. Radiology, however, proceeds from visual findings to disease through published guidelines that make this decision rule explicit, interpretable, and reproducible. We introduce diagnosis by composition (DbC), a representation learning framework that encodes this findings-first logic. DbC learns a vocabulary of radiological findings by aligning image features with the text embeddings of the findings, each finding represented as a dense map over the scan. A disease is defined by a set of required findings derived from its guidelines, and its diagnosis map is a fixed, parameter-free composition of the corresponding finding maps. Because the finding-to-disease mapping is derived from guidelines rather than learned, DbC is interpretable and auditable by design, can extend to new diseases by specifying their findings without retraining, and can diagnose unseen diseases by composing their findings. On multi-phase liver CT, DbC detects and localizes unseen diseases, rare diseases from a different institution, and an external cohort significantly better than all comparators, including models that align images with disease names. DbC also improves detection and localization in the fully supervised setting and remains superior across training-set sizes. Although demonstrated on liver CT, DbC applies wherever radiological guidelines define diseases through findings.

0.23

Reinforcing intra-operative tumour localisation with weak supervision from pre-operative appearances

cs.CV ·2026-10-22 ·Sidhart Sami, Ali Sharjeel, Sri Atluri, Miao Zhao, Caroline Roney +2 more
similarity 0.65
Abstract

Limited tumour visibility on intra-operative images complicates surgical navigation, including liver hepatocellular carcinoma (HCC) targeting on computed tomography (CT) imaging. This makes labelled datasets difficult to curate for deep learning, and transferring pre-operative delineations through registration remains challenging due to intra-operative deformation and lack of paired pre- and intra-operative data. We propose to transfer tumour appearances learned from pre-operative magnetic resonance (MR) images to guide localisation on intra-operative CT through weak supervision. A classifier is trained to classify tumour presence on pre-operative images. This is applied to windows on intra-operative images, and despite the domain gap, it assigns higher tumour-presence probabilities on average to tumour-containing windows. These weak cross-domain signals guide a reinforcement learning agent to localise tumours on intra-operative images. We compare direct transfer, few-shot adaptation and synthetic transfer (trained using unpaired MR and CT), which translates CT into synthetic MR before localisation. On an external HCC cohort, synthetic transfer outperformed other tested methods and CT-only baselines. Our framework enables cross-modality tumour localisation without paired MR-CT training images.

0.22

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.65
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40